Within the hematopoietic lineage, the monoclonal antibody (MoAb) CD66 reacts with cells of the granulocyte lineage, but not with the majority of progenitor cells from human bone marrow. Our previous studies have shown that CD66 binds specifically t o a t least three carcinoembryonic antigen KEA) superfamily members, ie, CEA itself, nonspecific crossreacting antigen INCA), and CGM1, but n o t t o CGM6 (NCA-95). In this report, we show that CD66 will also identify the biliary glycoproteins (BGP). A full-length cDNA for the BGPc molecule (a cytoplasmic splice variant of BGPa) was isolated by expression cloning using the CD66 MoAbs. This protein has an identical extracellular and transmembrane sequence t o BGPa with one N-terminal IgV like domain, three lgC-like extracellular domains (Al, BI, and A2). plus a transmem-HE CARCINOEMBRYONIC antigen (CEA) superfamily has been arbitarily divided into two subgroups: the membrane bound CEA subfamily and the secreted pregnancy-specific glycoprotein (PSG) subfamily. Within these groups, at least 29 different CEA-related cDNAs or genes have been identified and these are tandemly arranged on the long arm of chromosome 19 (19q13.1-3)." Although these molecules are highly homologous at both the nucleotide and amino acid levels, higher homology is seen withh a subgroup than between subgroups.' Additional heterogeneity within this family is generated by either differential glycosylation or splicing of some of its members.'
HE CARCINOEMBRYONIC antigen (CEA) superfamily has been arbitarily divided into two subgroups: the membrane bound CEA subfamily and the secreted pregnancy-specific glycoprotein (PSG) subfamily. Within these groups, at least 29 different CEA-related cDNAs or genes have been identified and these are tandemly arranged on the long arm of chromosome 19 (19q13. [1] [2] [3] ." Although these molecules are highly homologous at both the nucleotide and amino acid levels, higher homology is seen withh a subgroup than between subgroups.' Additional heterogeneity within this family is generated by either differential glycosylation or splicing of some of its members. ' The CEA-related proteins so far described are members of the Ig superfamily: with the extracellular region having a structure consisting of a leader or signal peptide, an IgVlike N-terminal domain, and a variable number of or no IgC-like domains.' The membrane-linked CEA subfamily members may be anchored into the plasma membrane via glycosyl phosphatidyl inositol (GP1)-linkage of the carboxy terminal domain or may occur as transmembrane proteins, which possess cytoplasmic tails of variable length.5, 6 The former GPI-linked proteins include CEA itself and the differentially glycosylated nonspecific cross-reacting antigen brane domain, but the cytoplasmic domain is spliced by 53 nucleotides. Reverse transcriptase-polymerase chain reaction experiments show that this splice variant can be detected in colonic carcinoma cell lines, in primary colonic adenocarcinomas, and in myeloid and B-cell lines t o varying degrees. Quantitative analyses of BGPc RNA expression by RNase protection indicate that abundant levels occur only in the colonic, but not in the hematopoietic, cell lines tested. Studies presented here show that BGPc mediates homotypic adhesion and suggest that the cytoplasmic splicing does not alter the initial homotypic adhesion properties of BGPa. 0 1994 by The American Society of Hematology.
(NCA), whereas the latter are represented by the biliary glycoprotein (BGP), CGMl, and CGM7 molecules.' Variants of BGP and CGMl are generated by splicing of the extracellular IgC2-like domains and/or the cytoplasmic tail.'.' Additional diversity may occur with the production of secreted forms of BGP and CGM1, although their protein products have as yet not been identified. '.9 The function of the CEA superfamily members is being investigated at present and these molecules are thought to act as both homotypic and heterotypic adhesion molecules.'O~'' Examples of the latter include (1) the presentation of sLex carbohydrate moieties by NCA and BGP on mature neutrophil~,'~.'' thereby providing ligands for the E-selectins on activated endothelium, and (2) the presence of RGD (arggly-asp) sequences in the N-terminal domain of some PSG subgroup possibly allowing these molecules to mimic matrix proteins and/or act as negative regulators of adhesion by interfering with receptor-ligand interactions.
Monoclonal antibodies (MoAbs), clustered as CD66,'y~2') identify NCA, CGMl, and a variety of CEA-related molecules with molecular weights between 80 and 200 kD.*.'"*' Our aim in this report has been to identify additional molecules recognized with CD66 MoAbs and to begin to examine their expression patterns and adhesion functions.
MATERIALS AND METHODS

Cells Lines and MoAbs
All cell lines, except Chinese hamster ovary (CHO), were maintained in RPMI-1640 medium with 10% to 20% (wt/vol) fetal calf semm (FCS) and diluted to 2 X 10' cells/ml with fresh medium on the day before analysis. CH0 cell transfectants were grown in Ham's F10 medium with 10% (wt/vol) FCS. library was obtained and was completely sequenced using "S-dATP labeling together with the Sequenase kit and the Sequagel sequencing system (National Diagnostics, Aylesbury, UK) in accordance with the manufacturer's instructions. The presence of potential asparagine linked glycosylation and phosphorylation motifs were analyzed using Macpattern software.'
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Transfectants
BGPc-(in the sHM3 vector) and CD34-(in the pCDM8 vector) defined CDNAS"' or the pSV2neo plasmid*' were linearized with S$ I, HindlT1, or BarnHI, respectively, electroporated into C H 0 cells, selected in 0.5 mglmL G418, and stained with the appropriate MoAbs. Stable CHO-CD34 and CHO-BGPc tnnsfectants were selected by two cycles of panning on goat antimouse Ig Cellector flasks (Applied Immune Sciences, Santa Clara, CA). Cells were then labeled with the appropriate MoAbs together with fluorescein (F1TC)-conjugated rabbit F(ab)? antimouse or antirat lg (Dakopatts, Copenhagen, Denmark) and cells within the top I O 8 to 30% of fluorescence were sorted on the FACStar plus (Becton Dickinson) Nontransfected CH0 cells were used as negative controls. Cos 7 cells were transfected with cDNAs encoding BGPc and VCAM-I" or mock-transfected using DEAE-dextran and used 3 days later.
Cell-Cell Aclhesion Assays
Cell lines were labeled overnight with 'H-thymidine" and added to Cos 7 cells transiently expressing BGPc and VCAM-I or to mocktransfectants for 2 hours at room temperature before analysis of the adherent cells by &scintillation counting."
Electron Microscopv
For pre-embedding labeling, confluent C H 0 cell transfectants on Thermanox coverslips were lightly fixed with 3% (wt/vol) paraformaldehyde in 0.1 molL Sorensen's phosphate buffer (pH 7.4) for 30 minutes at 4°C. washed three times in Sorensen's phosphate buffer containing S0 mmol/L glycine to quench aldehyde groups, preincubated for 30 minutes at 4°C in 10% (vollvol) normal goat serum (NGS) plus l % (wt/vol) bovine serum albumin (BSA) in phosphate-buffered saline (PBS; 0.02 mollL sodium phosphate buffer with 0.127 moVL NaCI, pH 7.4; PBS-RSA). washed twice in 0. 18 cells were washed with distilled water, postfixed with 2% (wt/vol) osmium tetroxide in Sorensen's phosphate buffer at room temperature for 2 hours, buffer-washed, and embedded in cross-linked 20% (wt/vol) RSA to allow routine dehydration and embedding in Araldite resin; the subsequent ultrathin sections (80 to I O 0 nm thick) were stained with uranyl acetate for 10 minutes and examined with a Zeiss I0C electron microscope (Carl Zeiss. Oberkochen, Germany). As negative controls, the primary antibody was omitted from procedure to visualize any nonspecific binding of colloidal gold particles on cell surfaces or CHO-CD34 cells were stained using the YTH71.3.2 MoAh as above.
Confi>cal Microscopy and Now Cjtometn
Confluent C H 0 cell transfectants on plastic two chamber slide flasks were air-dried, fixed in 80% (wt/vol) acetone in PBS for 10 minutes at -20°C, washed with PBS-BSA, and stained with YTH71.3.2 or QBend 10 at saturating concentrations, followed by FITC-conjugated rabbit F(ab)' antirat or antimouse Ig (Dakopatts) before analysis on the confocal microscope (Biorad. Hemel Hempstead. Herts, UK).
Suspended cells in PBS-BSA and 0.05% (wt/vol) heat-inactivated human y-glohulin were added to saturating concentrations of MoAbs followed hy FITC-rabbit F(ab)? antimouse or antirat Ig (Dakopatts) and then analyzed on a FACScan (Becton Dickinson).
Polvrnerase Chain Recrction (PCR) Anolvses and RNase Protection
cDNA libraries".'" prepared from the myeloidlmultipotential progenitor cell lines, KGI, KG1 A and KG1 h; U937 and HL-60. after induction to monocytic differentiation with y-interferon and PMA; the T-cell line, YT; and the colonic cell line, HT-29. were analyzed for the presence of BGPc cDNA. Because BGPc is identified specifically by the presence of both the A2 domain and a shortened cytoplasmic tail (cyt) (see Results). sequences spanning the BI to A2 and A2 to short cytoplasmic domains were amplified from the cDNA libraries by PCR using 4 cycles of 94°C for I minute, 45°C for 2 minutes. and 72°C for I minute, followed by 30 cycles of amplification at 94°C for 30 seconds, 45°C for 30 seconds, and 72°C for I minute; both sets of cycles were performed with Taq Polymerase together with oligonucleotide primers (i), (ii). (iii). and (iv), respectively. in Table I . These were designed to amplify across exon boundaries to prevent detection of any genomic DNA. The PCR products were analyzed on 2.5% (wtlvol) agarose gels using dX174 DNA markers and were stained with ethidium bromide.
Total RNA was prepared from cells and cell lines by either the method of Chomczynski and Sacchi'" using RNAzol for 2 hours at 37°C and then heated to 95°C for 5 minutes. The cDNAs generated were amplified by PCR using primers (i) and (ii) for the B1 to A2 domains and (iii) and (iv) for the A2 to short cytoplasmic domains (Table l) , and 30 cycles of 95°C for 1 minute, 60°C for 2 minutes, and 72°C for 2 minutes. For the myeloid and lymphoid cell lines, 60 cycles of amplification were used. PCR samples together with I-kb DNA markers (Boehringer Mannheim) were electrophoresed on 2 8 (wt/vol) agarose minigels and visualized by staining with ethidium bromide.
For RNAse protection,2"." a BGPc probe spanning the A2 to short cytoplasmic domain of BCPc (BGPc[A2-Cyt] sequence) was prepared by PCR amplification using primers (iii) and (iv) in Table  I and subsequently ligated into Bluescript SK as above. A GAPDH Alu fragment from 742 to 983 bp of the sequence described by Edwards et al" in the Pvz vector was generously provided by Dr David Bentley (ICRF, London. UK) "P-labeled sense and antisense RNA probes of the EcoR1 or Hindlll linearized BGPc (A2-cyt) containing vector and antisense RNA probes of the Xhn I linearized GAPDH containing vector were generated by transcription using T3 or T7 polymerase together with the riboprobe II core system (Promega) in the presence of d'P-UTP, as detailed by the manufacturer, digested with RNase-free DNase1 (Boehringer Mannheim), phenol/ chloroform-extracted, ethanol-precipitated, and purified on a 6% denaturing polyacrylamidell mol/L urea sequencing gel. were electrophoresed on 6% denaturing sequencing gels before exposure to x-ray film at -70°C.'"''
RESULTS
CD66 identijes BGP
Expression cloning procedures presented here show that the CD66 MoAbs, YTH71.3.2 and CE6/2D3.1, together with the YPC2/12.1 MoAb, identify the BGP molecule, a transmembrane member of the CEA family. Full sequence analysis and the predicted amino acid and domain structures are presented in Fig 1A and show that the BGPc molecule isolated from the HT29 cDNA library is a splice variant of BGPa34 with identical ECD and transmembrane sequences, but spliced by 53 nucleotides in the cytoplasmic domain. A schematic representation of the IgV-like N-terminal domain, the IgC2 set domains (AI, B 1, and A2), the transmembrane region (TM), and the cytoplasmic tail is indicated in Fig IB. This provides the first full-length cDNA clone of the BGPc WATT ET AL splice variant predicted by Barnett et with the presence of the A2 domain and the shortened cytoplasmic tail distinguishing this BGPc molecule from other BGP splice variants. However, two differences were observed at the 3' end of the sequence from that predicted. These were a T deletion at the 1,426-bp position and a change in sequence to CTT at the 1,471-bp position before linkedvector attachment. The BGPc ECD is highly glycosylated, with 20 predicted asparagine-linked sites, but it appears to lack potential protein kinase C and tyrosine phosphorylation motifs2s in its cytoplasmic tail. 
Expression of BGPc in Cell Lines
A series of cDNA libraries was examined by PCR analysis for the BGPc cDNA. Because the BGPc splice variant can be distinguished from other splice variants by the A2 domain and short cytoplasmic tail, PCR primers were designed to amplify sequences spanning the B 1 to A2 exons and the A2 to short cytoplasmic exon. Predicted PCR products of 290 bp (Fig 3, gel 1 , lane H) and 329 bp (Fig 3, gel 2 , lane H) were generated for the A2 to cyt segment and for the B1 to A2 segment, respectively, when the HT29 colonic carcinoma cell library was analyzed, indicating that this was the only library tested to contain BGPc cDNA. All other cDNA libraries tested were negative except for that derived from the U937 cell line (induced to macrophage differentiation), which generated the 329-bp B 1 to A2 product only (compare Fig 3, gel 1 with gel 2, lane E) . Thus, the U937 library probably camed the BGPa rather than the BGPc cDNA.
Expression of the BGPc gene product was examined in a variety of uninduced myeloid, lymphoid, and colonic cell lines and in primary adenocarcinomas using the RT-PCR technique to detect the A2 domain and the short cytoplasmic tail of BGPc. The B1 to A2 (Fig 4, gel 1 ) and A2 to short cyt domain (Fig 4, gel 2 The U937 cell line generated the 329-bp B1 to A2 product only (compare Fig 4, gel 1 with gel 2 , lane K), as was observed for the U937 cDNA library. Because 60 cycles of PCR amplification were used to detect these transcripts in myeloid and lymphoid cell lines (suggesting that only minor levels of BGPc might be expressed), an RNAse protection assay using a probe covering the A2 to short cyt domains was performed to quantitate the BGPc RNA levels in a representative set of these cell lines. Figure 5 shows that, although a protected RNA fragment was observed with the GAPDH probe (gel A) when 40 pg of RNA from the cell lines was tested, no protected fragment was observed when the antisense BGPc probe was used for the uninduced myeloid or For personal use only. on April 14, 2017. by guest www.bloodjournal.org From 
7ED COS CELLS
B-cell lines, nor for the promonocytic U937 cell line either before or after these had been induced to macrophage differentiation with PMA (gel B). However, a protected fragment of the correct molecular weight was obtained for thc colonic cell line HT29 (gel B). No protected fragments were found for the sense BGPc probe nor when KG1 and KGlb cell lines were analyzed either with sense or antisense BGPc (A2-Cyt) probes (data not shown).
Adhesion Properties of BGPc
Cell-cell ndlwsion. Previous studies have indicated that the BGPa cDNA, when transfected and stably expressed in C H 0 cells, mediates homotypic adhesion." Our preliminary observations" also indicated that CHO-BGPc, but not CHO-CD34, transfectants would aggregate, suggesting that splicing of BGPa in the cytoplasmic domain does not affect this initial adhesion. This was examined in more detail. Cos cells transiently expressing BGPc or VCAM-I (as a positive control) were analyzed for their adhesion to a variety of uninduced cell lines representing T (Molt 4, CEM), B (Ramos, Raji, Daudi), myeloid (HL-60, U937), erythroid (K562). and colonic epithelial (HT29) cells. Initial phenotypic analyses showed that all cell lines, except HT-29, expressed VLA-4 I RELATIVE CELL BINDING -(one ligand for VCAM-I). Because MoAbs specific to the BGPc splice variant are not available, the presence of CEArelated molecules was determined with the CD66 MoAb. In contrast to VLA-4 expression, HT29 cells reacted strongly with the CD66 MoAb. YTH71.3.2, whereas all other cell lines showed either low (HL-60) or negligible (U937) binding. The phenotypes of representative cell lines are presented in Fig 6A and B. As expected, all cell lines except HT29 bound to VCAM-I -expressing Cos cells (Fig 6C) , with substantial binding of HT29 cells and with lesser binding of HL-60 and U937 cells (Fig 6C) to Cos cells expressing BGPc. Other cell lines representing erythroid (KS62) and lymphoid (Ramos and CEM) cells, which did not react to any significant degree with CD66 MoAb, showed negligible levels of adhesion to BGPc transfectants (Fig 6C and data  not shown) . BGPc 1occrlize.s to sites of cell-cell contrrct. Confluent CHO-BGPc cells were stained with CD66 MoAbs and examined by confocal microscopy. Figure 7 shows that BGPc molecules localize at sites of cell-cell contact. This was confirmed by electron microscopy using an immunogold labeling procedure (Fig 8) . With the pre-embedding labeling method, BGPc molecules localized at cell-cell junctions only where cells were loosely connected and not at tight junctions (Fig 8B) . This undoubtedly reflects an antibody access problem as post-embedding labeling showed BGPc molecules also occurred along these tight junctions (N.A. Hajibagheri and S.M. Watt, unpublished data). Our own preliminary results indicate that, at the RNA level, the BGPc splice variant can be detected in primary colonic carcinomas, colonic carcinoma cell lines, and, after extensive PCRing, in myeloid and B-lymphoid cell lines, but not in a monocytic cell line, U937. Quantitating this BGPc RNA expression in a set of set lines using an RNase protection assay shows that it is expressed most abundantly in the colonic, but, using an equivalent RNA concentration, was not detected in the immature myeloid cell lines, the B-cell lines, or in the monocytic cell line, U937, either before or after macrophage induction. This is consistent with the much higher level of staining with the CD66 MoAbs in colonic as opposed to hematopoietic cell lines and with the detection of other splice variants such as BGPa and b in immature and mature myeloid ~ells.'~..''.~'
Because the BGPc molecule is identical to BGPa in its extracellular domain and because it carries at least some of the same domains as the other splice variants, it seems likely that BGPc will share functions with these molecules, while perhaps also possessing its own specific functions. Initial experiments before the identification of BGP splice variants suggested several functions for BGP. Firstly, BGP, together with NCA, on mature neutrophils is thought to present sialyl Le" oligosaccharide moieties,'".'s thereby mediating neutrophil adhesion to E-selectin molecules, such as ELAM-l, on activated end~thelium.d'.~.' Secondly, BGP has the ability to bind bacteria@ in a mannose-dependent manner and appears to regulate normal bacterial colonization of the gut. Whether the BGPc splice variant possesses these functions remains to be determined. As far as the BGP splice variants are concerned, only BGPa and b have been analyzed to any extent and these possess both homotypic and heterotypic adhesion properties, being able to bind to BGPa and b as well as to CEA and NCA, but not to CGM6."".' The relztionship For personal use only. on April 14, 2017. by guest www.bloodjournal.org From
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WATT ET AL between the extracellular domains of the BGP molecules and the long and short cytoplasmic tails also remains to be elucidated. Because it was possible that cytoplasmic splicing of BGPc might modify the adhesion functions of its extracellular domain, we isolated a full-length clone of BGPc to analyze its adhesive functions. Our studies show that C H 0 transfectants expressing BGPc retain the ability to aggregate in a homotypic manner.*' Thus, splicing of the cytoplasmic tail does not appear to affect the initial adhesion properties of BGPc, although it may alter the affinity or ligand specificities of such interactions. It is interesting to note that the transmembrane members of the CEA family, BGP, CGMl, and CGM7, carry at their N-terminal end of their cytoplasmic tails conserved putative protein kinase C phosphorylation site^.^.^' Splicing of BGPa to give BGPc results in the loss of potential tyrosine phosphorylation sites, but not serine or threonine residues. This suggests that phosphorylation may be important in signal transduction and in regulating the biochemical and biologic properties of these molecules, as is evident for LFA-1.45 Analysis for such phosphorylation motifs shows three protein kinase C phosphorylation sites in the cytoplasmic tail of BGPa and b, which are spliced out in the BGPc splice variant. Thus, although BGPa and c may both be able to mediate adhesion events, they may transduce different intracellular signals.
Studies in rodents indicate a similar homotypic function for mmCGMU2 and C-CAM-105, the respective mouse and rat equivalents of human BGP,46-48 possibly mediating hepatocyte adhesion and organization of the microvilli of the intestinal brush border. Lin and G~i d o t t i~~ have shown an ecto-ATPase activity for C-CAM-105, and have suggested a similar function for the human BGP molecule. In addition, these investigators have suggested that the location of the rat C-CAM-105 or ecto-ATPase may determine its function, with the sinusoidal ecto-ATPase acting as a ligand for the P2-purinergic receptors and the canalicular ecto-ATPase forming a retrieval system for adenosine recovery. The cytoplasmic tail of the rat C-CAM-105 molecule is also a substrate for the insulin receptor tyrosine kinase.50 Further studies indicate that the murine equivalent of BGP acts as a receptor for coronaviruses such as the mouse hepatitis vivariant expressed in a particular cell lineage or in a particular species and its degree of phosphorylation will determine its specific function. Further studies are therefore needed to determine both the expression patterns and functions of these BGP splice variants. These will be greatly assisted by the availability of full-length cDNA clones of such molecules.
